Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-07-08

Clinical Trial Update: Methenamine in a Non-antibiotic, Multimodal Approach to UTI Prevention [Phase 4]

View source ↗

Summary

Phase 4 trial of methenamine for non-antibiotic, multimodal UTI prevention has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methenamine (Methenamine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: UTI, Female Urogenital Diseases | Phase 4 | Status: WITHDRAWN